fda warning letters compounded semaglutide 2025 september issued 30 to telehealth companies for false and misleading claims about GLP-1 products. This marks the second round of enforcement action since the agency's crackdown on misleading Hims is in the crosshairs.
Description
Analogs based on the human GLP-1 structure have also been developed [10,11]
While these natural approaches won't produce the dramatic effects seen with prescription GLP-1 medication, they can support healthy weight management, improve metabolic health, and potentially enhance the effects of medication if you're taking it
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease
22 Outcomes Birth defects were classified by two independent coauthors (MCA, DB) who were blinded to exposure data
10.1097/FBP.0000000000000609 13 EdvardssonC
Appleton highlighted several important remaining gaps in the understanding of GLP-1-based therapies for OA
